← Open Payments lookup

CAROLYN REKERDRES: Open Payments

NPI 1104020346 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$134,684 in 218 payments from 8 companies in 2025. Trend: 2023 $471 · 2024 $122,869 · 2025 $134,684

Speaker / faculty: $106,035Travel & lodging: $18,258Consulting: $6,660Food & beverage: $3,619Education: $111
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc110$108,794
ABBVIE INC.37$24,787
Teva Pharmaceuticals USA, Inc.17$282
Alkermes, Inc.15$268
E.R. Squibb & Sons, L.L.C.25$212
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$183
Neurocrine BioSciences, Inc.5$140
Otsuka America Pharmaceutical, Inc.1$19

Products named: INVEGA SUSTENNA, VRAYLAR, COBENFY, ARISTADA, CAPLYTA, INGREZZA, SPRAVATO, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.